Condition
Dengue Fever clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Dengue Fever clinical trials that are recruiting, at sites in 6 countries (most in Thailand (3), Colombia (2), Brazil (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Dengue Fever clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Registry of dengue infection in people with congenital bleeding disorders | — | Bangkok | Recruiting | Feb 13, 2026 |
| Risk factors for hospitalization and transfusion criteria in dengue patients | — | Piedras Negras, Coahuila | Recruiting | Jun 6, 2025 |
| Resomelagon in Dengue Infection: Safety and Function in Adults | Phase 2 | Belo Horizonte, Minas Gerais and 1 other locations | Recruiting | Apr 8, 2025 |
| Effectiveness of Dengue Vaccine in Children and Adolescents | — | Banjarmasin, South Kalimantan and 6 other locations | Recruiting | Feb 24, 2025 |
| Two-dose tetravalent dengue vaccine for infants and toddlers | Phase 3 | Barranquilla, Atlántico and 3 other locations | Recruiting | Oct 30, 2024 |
| Zanamivir treatment for severe dengue symptoms | Phase 2 | Barranquilla, Atlántico and 1 other locations | Recruiting | Oct 22, 2020 |
All recruiting trials (6)
-
Registry of dengue infection in people with congenital bleeding disorders
This registry will collect information to see how dengue affects people with congenital bleeding disorders, such as hemophilia and von Willebrand disease, and what treatments and outcomes occur.
-
Risk factors for hospitalization and transfusion criteria in dengue patients
This project will try to find which clinical signs and lab results predict whether people aged 5 and up with confirmed dengue will need hospitalization or a blood transfusion.
-
Resomelagon in Dengue Infection: Safety and Function in Adults
This study tests whether Resomelagon can be safely given to adults with dengue fever to see if it shortens illness compared with placebo.
-
Effectiveness of Dengue Vaccine in Children and Adolescents
This study is testing how well a new dengue vaccine works to keep children and teens in Southeast Asia out of the hospital due to dengue fever.
-
Two-dose tetravalent dengue vaccine for infants and toddlers
This will test whether two doses of a tetravalent dengue vaccine given three months apart are safe and help children aged 6 to under 21 months develop protective immune responses.
-
Zanamivir treatment for severe dengue symptoms
This study is testing if an intravenous treatment called zanamivir can help reduce severe symptoms in people with dengue fever, especially those at risk of serious complications.
Related topics
Quick answers
How many Dengue Fever clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Thailand (3 trials), Colombia (2 trials), Brazil (1 trial), Mexico (1 trial), Indonesia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.